Research To Practice открытые
[search 0]
Больше

Download the App!

show episodes
 
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
 
The official podcast of the Australasian Society for Intellectual Disability (ASID). We bring you the latest in Australian and New Zealand research into improving the rights and quality of life for people with intellectual disability. Find out more about ASID at our website http://asid.asn.au/ or follow us on social media: Twitter @ASID_Ltd Facebook: @asid.asn.au .
 
Loading …
show series
 
Featuring perspectives from Dr Richard Stone, including the following topics: Current and future trends in the care of patients with acute myeloid leukemia (AML) (0:00) Management of AML with IDH1/2 and FLT3 mutations (17:28) Advances in the treatment of high-risk AML (29:42) Emerging data with novel therapies for AML with targetable mutations (36:…
 
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma — Faculty Presentation 2: Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Other Novel Approaches for MM — Dr Ajay Nooka CME information and select publicationsDr. Neil Love
 
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma — Faculty Presentation 1: Optimizing the Current Management of Multiple Myeloma (MM) — Dr Joseph Mikhael CME information and select publicationsDr. Neil Love
 
Featuring perspectives from Drs Joseph Mikhael and Ajay Nooka, including the following topics: Introduction (0:00) Front-Line Treatment; Autologous Stem Cell Transplant (11:36) Use of Anti-CD38 Antibodies (29:36) CAR T-Cell Therapy (38:16) Treatment with Bispecific Antibodies (48:59) Other Treatments for Relapsed/Refractory Disease (56:07) CME info…
 
Featuring perspectives from Drs Erica Mayer and Ruth O’Regan, including the following topics: Pregnancy during adjuvant endocrine therapy; fertility issues (0:00) Genomic biomarkers in the adjuvant setting (16:28) CDK4/6 inhibitors in metastatic disease (31:58) Adjuvant use of CDK4/6 inhibitors (47:42) Novel agents in metastatic disease (1:14:26) C…
 
Featuring a slide presentation and related discussion from Professor Giuseppe Curigliano, including the following topics: Recent data with targeted therapies for patients with HER2-positive metastatic breast cancer (0:00) Case: A woman in her early 40s with a new right breast tumor 10 years after adjuvant radiation and endocrine therapy (17:17) Cas…
 
Featuring an interview with Professor Giuseppe Curigliano, including the following topics: Vision for treating and curing HER2-positive metastatic breast cancer (mBC) in the future (0:00) Optimal treatment of HER2-positive mBC with brain metastases (7:42) Screening for and management of T-DXd-related interstitial lung disease (17:32) Gastric toxici…
 
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer — Faculty Presentation 2: Therapeutic Approaches for Patients with Other Actionable Genomic Alterations — Dr Gregory Riely CME information and select publications…
 
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer — Faculty Presentation 1: Management of Non-Small Cell Lung Cancer with an EGFR, ALK or ROS1 Abnormality — Dr Zofia Piotrowska CME information and select publications…
 
Featuring perspectives from Drs Zofia Piotrowska and Gregory Riely, including the following topics: Introduction: What Is Targeted Therapy? (0:00) EGFR-Activating Mutations (12:23) EGFR Exon 20 Insertion Mutations (27:54) ALK and ROS1 Rearrangements (31:31) HER2 Mutations (36:17) NRG1 Fusions (45:39) RET Fusions (49:07) MET Exon 14 Mutations (53:10…
 
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia — Faculty Presentation 2: Treatment of Relapsed/Refractory CLL; Novel and Investigational Strategies — Dr Deborah Stephens CME information and select publicationsDr. Neil Love
 
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia — Faculty Presentation 1: Optimizing the First-Line Management of Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) — Dr Jennifer Brown CME information and select publications…
 
Featuring perspectives from Drs Jennifer Brown and Deborah Stephens, including the following topics: Introduction: First-Line Treatment of Chronic Lymphocytic Leukemia (0:00) Combining Bruton Tyrosine Kinase (BTK) Inhibitors with Venetoclax; Venetoclax Consolidation (36:57) Noncovalent BTK Inhibitors; Pirtobrutinib (42:59) CAR T-Cell Therapy; Lisoc…
 
Loading …

Краткое руководство